ACHIEVE LIFE SCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.69 USD | +3.76% |
|
+3.30% | +13.83% |
| 17/04 | JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target | MT |
| 28/03 | Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
Chart calendar Achieve Life Sciences, Inc.
88320.RMXsHKt4_zMGLO49Pnn2m9asIxYfjR-zAqtshbvCqHU.cZSKa8Q1h1JZFJtMDBqSybf-Rk5nuG7SZeBezYn7mxAhs4Fo_hnMVmxD2g~719b17e772b101e1f3e32251f58527bc
Upcoming events on Achieve Life Sciences, Inc.
Past events on Achieve Life Sciences, Inc.
| 02/05/2024 | Planet MicroCap Showcase |
| 19/04/2024 02:20 am | Life Science Innovation Northwest Conference |
| 29/03/2024 02:00 am | Q4 2023 Earnings Call |
| 29/03/2024 01:31 am | Q4 2023 Earnings Release |
| 23/03/2024 03:15 pm | Society for Research on Nicotine and Tobacco Meeting - Dr. Nancy Rigotti |
| 22/03/2024 02:00 pm | Society for Research on Nicotine and Tobacco Meeting - Dr. Cindy Jacobs |
| 21/03/2024 05:00 pm | Society for Research on Nicotine and Tobacco Meeting - Roxann Becco |
| 13/03/2024 | Leerink Partners Global Biopharma Conference |
| 07/03/2024 11:30 pm | OTC Markets Life Science Investor Forum |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 14/12/2023 09:00 pm | Life Sciences Investor Forum |
| 10/11/2023 03:00 am | Q3 2023 Earnings Call |
| 10/11/2023 02:30 am | Q3 2023 Earnings Release |
| 12/10/2023 | Dawson James Small Cap Growth Conference |
| 09/10/2023 | JonesTrading Healthcare Summit |
| 28/09/2023 05:30 pm | Cantor Global Healthcare Conference - Fireside Chat |
| 14/09/2023 | Lake Street Best Ideas Growth Conference |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference |
| 11/09/2023 | Society for Research on Nicotine and Tobacco Europe Meeting |
| 15/08/2023 06:00 pm | Q2 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,03 - | 0,00 0,07 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -14,9 0,00 - | 0,00 0,00 - | -32,8 -32,0 -2.64% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -16,5 -17,0 2.81% | -14,8 -14,5 -2.02% | -33,1 -32,7 -1.21% | -40,8 -41,4 1.54% | -27,3 -29,3 7.06% | -33,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,4 -16,8 2.61% | -14,7 -14,5 -1.49% | -33,2 -32,5 -1.86% | -42,4 -42,1 -0.62% | -29,8 -31,0 3.84% | -34,3 |
|
Net income Million USD | Released Forecast Spread | -16,4 -16,8 2.61% | -14,7 -14,5 -1.93% | -33,2 -32,7 -1.32% | -42,4 -42,8 1.09% | -29,8 -31,1 4.07% | -33,9 |
|
EPS USD | Released Forecast Spread | -39,8 -36,0 -10.71% | -5,42 -5,78 6.2% | -4,08 -3,94 -3.68% | -4,00 -3,98 -0.5% | -1,50 -1,57 4.2% | -1,06 |
| Announcement Date | 13/03/20 | 11/03/21 | 10/03/22 | 16/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,03 - | 0,00 0,00 - | 0,00 0,04 - | 0,00 0,04 - | 0,00 0,08 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,12 -6,71 -6.03% | -7,23 -7,71 6.23% | -10,1 -8,19 -23.05% | -12,6 -10,8 -16.82% | -10,9 -11,8 8.03% | -8,58 -10,6 18.75% | -7,71 -7,95 2.94% | -6,57 -7,58 13.26% | -4,39 -6,45 31.95% | -6,25 | -7,15 | -9,25 | -10,9 | -11,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,15 -6,55 -9.24% | -7,57 -6,86 -10.4% | -10,5 -7,95 -31.69% | -13,1 -10,6 -23.18% | -11,2 -11,7 4.1% | -8,99 -11,1 19.06% | -8,24 -8,23 -0.13% | -7,11 -8,35 14.85% | -5,48 -6,68 18.08% | -6,99 | -7,42 | -9,68 | -11,8 | -11,3 |
|
Net income Million USD | Released Forecast Spread | -7,15 -6,72 -6.41% | -7,57 -7,77 2.51% | -10,5 -8,24 -27.03% | -13,1 -10,9 -19.89% | -11,2 -12,2 7.58% | -8,99 -11,0 17.92% | -8,24 -8,29 0.58% | -7,11 -7,91 10.17% | -5,48 -6,74 18.77% | -6,54 | -7,43 | -9,53 | -11,2 | -11,3 |
|
EPS USD | Released Forecast Spread | -0,76 -0,69 -9.95% | -0,80 -0,80 0.21% | -1,08 -0,83 -29.54% | -1,35 -1,12 -20.27% | -0,83 -0,89 6.48% | -0,50 -0,69 27.11% | -0,43 -0,42 -2.03% | -0,34 -0,38 10.19% | -0,26 -0,31 17.27% | -0,25 | -0,23 | -0,28 | -0,31 | -0,28 |
| Announcement Date | 10/03/22 | 12/05/22 | 11/08/22 | 14/11/22 | 16/03/23 | 09/05/23 | 14/08/23 | 09/11/23 | 28/03/24 | - | - | - | - | - |
More events
Past sector events for Achieve Life Sciences, Inc.
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ACHV Stock
- Calendar Achieve Life Sciences, Inc.
